As of December 2024 Revance Therapeutics has a market cap of A$0.51 Billion. This makes Revance Therapeutics the world's 7474th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 25th, 2024 the market cap of Revance Therapeutics was reported to be: